Cargando…
Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity
BACKGROUND: Despite the fact of ongoing worldwide vaccination programs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), understanding longevity, breadth, and type of immune response to coronavirus disease-19 (COVID-19) is still important to optimize the vaccination strategy and esti...
Autores principales: | Kang, Chang Kyung, Kim, Minji, Hong, Jisu, Kim, Gwanghun, Lee, Soojin, Chang, Euijin, Choe, Pyoeng Gyun, Kim, Nam Joong, Kim, Ik Soo, Seo, Jun-Young, Song, Daesub, Lee, Dong-Sup, Shin, Hyun Mu, Kim, Yong-Woo, Lee, Chang-Han, Park, Wan Beom, Kim, Hang-Rae, Oh, Myoung-don |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980227/ https://www.ncbi.nlm.nih.gov/pubmed/35392102 http://dx.doi.org/10.3389/fimmu.2022.830433 |
Ejemplares similares
-
Corrigendum: Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity
por: Kang, Chang Kyung, et al.
Publicado: (2022) -
Different degree of cytokinemia and T-cell activation according to serum IL-6 levels in critical COVID-19
por: Lee, Chan Mi, et al.
Publicado: (2023) -
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
por: Kang, Chang Kyung, et al.
Publicado: (2022) -
Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity
por: Kang, Chang Kyung, et al.
Publicado: (2020) -
Kinetics of Neutralizing Antibody Responses Against SARS-CoV-2 Delta Variant in Patients Infected at the Beginning of the Pandemic
por: Choe, Pyoeng Gyun, et al.
Publicado: (2022)